Inovalon (NASDAQ:INOV) was downgraded by stock analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Thursday.

Other equities research analysts also recently issued reports about the company. TheStreet upgraded Inovalon from a “d+” rating to a “c-” rating in a report on Thursday, October 5th. Morgan Stanley upgraded Inovalon from an “underweight” rating to an “equal weight” rating and lifted their price objective for the stock from $9.00 to $14.00 in a report on Tuesday, September 12th. KeyCorp reiterated a “hold” rating on shares of Inovalon in a report on Tuesday, September 12th. ValuEngine upgraded Inovalon from a “sell” rating to a “hold” rating in a report on Wednesday, September 6th. Finally, Zacks Investment Research cut Inovalon from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th. Three investment analysts have rated the stock with a sell rating and five have given a hold rating to the company’s stock. Inovalon currently has a consensus rating of “Hold” and a consensus target price of $12.00.

Shares of Inovalon (NASDAQ:INOV) opened at $15.00 on Thursday. Inovalon has a twelve month low of $9.10 and a twelve month high of $17.80. The company has a market capitalization of $2,144.32, a PE ratio of 70.00, a P/E/G ratio of 4.30 and a beta of 1.24. The company has a debt-to-equity ratio of 0.31, a current ratio of 5.62 and a quick ratio of 5.62.

Inovalon (NASDAQ:INOV) last released its quarterly earnings data on Wednesday, November 1st. The technology company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.08 by $0.01. Inovalon had a return on equity of 4.63% and a net margin of 4.07%. The company had revenue of $115.90 million during the quarter, compared to the consensus estimate of $114.79 million. During the same period last year, the company earned $0.10 EPS. Inovalon’s revenue for the quarter was up 10.4% on a year-over-year basis. analysts predict that Inovalon will post 0.24 earnings per share for the current fiscal year.

In other Inovalon news, President Robert A. Wychulis sold 85,828 shares of the firm’s stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $15.54, for a total value of $1,333,767.12. Following the transaction, the president now directly owns 466,286 shares of the company’s stock, valued at $7,246,084.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Shauna L. Vernal sold 5,908 shares of the firm’s stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $16.01, for a total value of $94,587.08. Following the completion of the transaction, the insider now directly owns 47,309 shares in the company, valued at $757,417.09. The disclosure for this sale can be found here. Company insiders own 48.28% of the company’s stock.

A number of large investors have recently made changes to their positions in INOV. BNP Paribas Arbitrage SA boosted its position in Inovalon by 336.2% in the second quarter. BNP Paribas Arbitrage SA now owns 8,397 shares of the technology company’s stock worth $110,000 after purchasing an additional 6,472 shares during the last quarter. Advisor Group Inc. lifted its position in shares of Inovalon by 24.8% during the 2nd quarter. Advisor Group Inc. now owns 10,191 shares of the technology company’s stock valued at $134,000 after buying an additional 2,023 shares in the last quarter. Virtu KCG Holdings LLC purchased a new position in shares of Inovalon during the 2nd quarter valued at about $154,000. Principal Financial Group Inc. purchased a new position in shares of Inovalon during the 2nd quarter valued at about $157,000. Finally, Bank of Montreal Can lifted its position in shares of Inovalon by 0.4% during the 2nd quarter. Bank of Montreal Can now owns 14,006 shares of the technology company’s stock valued at $184,000 after buying an additional 61 shares in the last quarter. 28.09% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Inovalon (INOV) to Strong Sell” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another site, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this news story can be viewed at https://www.watchlistnews.com/bidaskclub-downgrades-inovalon-inov-to-strong-sell/1767431.html.

About Inovalon

Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

Analyst Recommendations for Inovalon (NASDAQ:INOV)

Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with MarketBeat.com's FREE daily email newsletter.